Search
for
Sort by
Research 271–300 of 1000+
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Developing Human Skin Contains Lymphocytes Demonstrating a Memory Signature
- 097 LFA-1 blockade prevents the onset of alopecia areata in C3H/HeJ mice
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Live Imaging of the Skin Immune Responses
- NIGELLA SATIVA L.: AN OVERVIEW
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Microbial harmony in female reproductive health: exploring the impact of intestinal flora on ovarian function and disease pathogenesis
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Evidence for murine cutaneous immune surveillance localized to hair follicle epithelium
- Mechanisms regulating skin immunity and inflammation
- Signaling in the stem cell niche: regulating cell fate, function and plasticity
- Extraskeletal actions of vitamin D
- Dermatophytosis in companion animals: A review
- Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application
- Roles of tumor suppressors in regulating tumor-associated inflammation
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Stem Cell-Based Tissue Engineering for the Treatment of Burn Wounds: A Systematic Review of Preclinical Studies
- Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy–like Autoimmune Disease
- The importance and use of stem cells in dermatology
- The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- Mesenchymal stem cell therapy for skin repair and rejuvenation
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- CD27 and IL-35 as diagnostic biomarkers in alopecia areata: First evidence of association with pathogenic scalp bacterial infections
- Immunological control of skin development: from homeostasis to developmental pathologies
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- AP-2α/AP-2β transcription factors are key regulators of epidermal homeostasis